InvestorX
SEDAR® Issuer number:
00043889
Company name:
Kalgene Pharmaceuticals Inc.
Document type:
Report of exempt distribution excluding Schedule 1 of 45-106F1
Project number:
03380826
Filing date:
05-09-2022